These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18473822)

  • 1. Cutaneous melanoma: fishing with chips.
    Nambiar S; Mirmohammadsadegh A; Hengge UR
    Curr Mol Med; 2008 May; 8(3):235-43. PubMed ID: 18473822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative array-based assay for omics pattern in melanoma.
    Dumitru C; Constantin C; Popp C; Cioplea M; Zurac S; Vassu T; Neagu M
    J Immunoassay Immunochem; 2017; 38(4):343-354. PubMed ID: 28613106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promise of microarray technology in melanoma care.
    Kim CJ; Reintgen DS; Yeatman TJ
    Cancer Control; 2002; 9(1):49-53. PubMed ID: 11907466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-expression profiling in human cutaneous melanoma.
    Carr KM; Bittner M; Trent JM
    Oncogene; 2003 May; 22(20):3076-80. PubMed ID: 12789283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
    Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
    Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.
    Stark M; Hayward N
    Cancer Res; 2007 Mar; 67(6):2632-42. PubMed ID: 17363583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.
    Pryor JG; Brown-Kipphut BA; Iqbal A; Scott GA
    Am J Dermatopathol; 2011 Dec; 33(8):780-5. PubMed ID: 21785329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
    Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
    Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma progression, gene expression and DNA microarrays.
    Hoek KS
    G Ital Dermatol Venereol; 2009 Feb; 144(1):39-49. PubMed ID: 19218910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic pathways to melanoma tumorigenesis.
    Hussein MR
    J Clin Pathol; 2004 Aug; 57(8):797-801. PubMed ID: 15280398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells.
    Cheng SL; Huang Liu R; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
    Biol Pharm Bull; 2006 Apr; 29(4):655-69. PubMed ID: 16595896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA microarray technology and its applications in dermatology.
    Kunz M; Ibrahim SM; Koczan D; Scheid S; Thiesen HJ; Gross G
    Exp Dermatol; 2004 Oct; 13(10):593-606. PubMed ID: 15447719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of melanocytic lesions.
    Seykora JT; Jih D; Elenitsas R; Horng WH; Elder DE
    Am J Dermatopathol; 2003 Feb; 25(1):6-11. PubMed ID: 12544092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid identification of dysregulated genes in cutaneous malignant melanoma metastases using cDNA technology.
    Mirmohammadsadegh A; Baer A; Nambiar S; Bardenheuer W; Hengge UR
    Cells Tissues Organs; 2004; 177(3):119-23. PubMed ID: 15388985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.
    Alonso SR; Ortiz P; Pollán M; Pérez-Gómez B; Sánchez L; Acuña MJ; Pajares R; Martínez-Tello FJ; Hortelano CM; Piris MA; Rodríguez-Peralto JL
    Am J Pathol; 2004 Jan; 164(1):193-203. PubMed ID: 14695333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.